Accutane Users Pledge Abstinence, or Commit to Test After Test

Let our journalists help you make sense of the noise: Subscribe to the Mother Jones Daily newsletter and get a recap of news that matters.


Six months ago the FDA launched iPLEDGE, a mandatory registry for users of Isotretinoin (commonly prescribed as Accutane), designed to keep its users pregnancy free. Given that the powerful acne medication that’s prescribed to 5 million Americans has been linked to serious birth defects and mental health problems, precautionary steps are understandable.

The FDA, caught in a tussle between patients wanting this extremely effective acne drug and those wanting it off the market, accepted iPLEDGE as a compromise to essentially improve behavior while taking a dangerous drug. But the requirements of the “computer-based risk management program” are so daunting it turns out people might be avoiding the drug altogether.

Women on the medication take mandatory pregnancy tests each month (two, one in a clinic), and have to take two forms of birth control at the same time. Or, they can pledge to “abstain from intercourse for one month prior to treatment, during treatment and for one month after treatment has ended.” Every month patients must repledge the two forms of birth control they are using. Those who get pregnant anyway must “agree to be queried by an agent of iPLEDGE.”

Male users have to sign on as well, and all users have to sign a document acknowledging that Accutane can increase risk for birth defects, depression, and suicidal thoughts.

Doctors and patients alike are complaining about the complicated $80 million system that requires everyone, patients plus all the people involved in the distribution of the drug to register: doctors, pharmacists and drug wholesalers included.

Each month prescribers must enter a female patient’s pregnancy test results into the system and the two forms of contraception she is using. The system then authorizes the doctor to prescribe, and the pharmacist to dispense, the drug. Yesterday, the Washington Post reported that the 15,000-member American Academy of Dermatology (AAD) released a survey finding:

-90% of 378 physicians are having problems with the program.

-Nearly 52% said patients’ treatments had been delayed because they were unable to pick up a prescription within seven days.

-39% said their patients encountered technical problems using the website.

The website itself is a curious sight. The tagline, “Committed to Pregnancy Prevention” has an icon that is a red stop sign with a big hand in the middle. The website features a big red arrow with the words “The Only Way” running across each page. Of the women on Accutane, 80% are under 30, “females of childbearing potential” and given the hoops women have to go through abstinence may be the best policy when taking the drug, or finding another drug.

One outgrowth of the system is that, if it survives, it will creates a national database tracking birth control use and behavior, as well as pregnancies and abortions, of Isotretinoin users. Somewhat far afield of treating acne. We’ll stay tuned to see how it plays out.

DOES IT FEEL LIKE POLITICS IS AT A BREAKING POINT?

Headshot of Editor in Chief of Mother Jones, Clara Jeffery

It sure feels that way to me, and here at Mother Jones, we’ve been thinking a lot about what journalism needs to do differently, and how we can have the biggest impact.

We kept coming back to one word: corruption. Democracy and the rule of law being undermined by those with wealth and power for their own gain. So we're launching an ambitious Mother Jones Corruption Project to do deep, time-intensive reporting on systemic corruption, and asking the MoJo community to help crowdfund it.

We aim to hire, build a team, and give them the time and space needed to understand how we got here and how we might get out. We want to dig into the forces and decisions that have allowed massive conflicts of interest, influence peddling, and win-at-all-costs politics to flourish.

It's unlike anything we've done, and we have seed funding to get started, but we're looking to raise $500,000 from readers by July when we'll be making key budgeting decisions—and the more resources we have by then, the deeper we can dig. If our plan sounds good to you, please help kickstart it with a tax-deductible donation today.

Thanks for reading—whether or not you can pitch in today, or ever, I'm glad you're with us.

Signed by Clara Jeffery

Clara Jeffery, Editor-in-Chief

payment methods

We Recommend

Latest